Probiotics and the development of very low birthweight infants: Follow-up study of a randomised trial

BMJ Paediatrics Open

Volumn 2, Issue 1, 2018, Pages

  Totsu, Satsuki ^a   Terahara, Masaki ^a   Kusuda, Satoshi ^b  

^a MEIJI DAIRIES CORPORATION   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OLB 6378; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

APGAR SCORE; ARTICLE; BRAIN HEMORRHAGE; CESAREAN SECTION; CONTROLLED STUDY; DEVELOPMENTAL DELAY; DQ18 SCORE; ENTERIC FEEDING; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NEWBORN MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VERY LOW BIRTH WEIGHT;

EID: 85062111534     PISSN: None     EISSN: 23999772     Source Type: Journal    
DOI: 10.1136/bmjpo-2018-000256     Document Type: Article

References (19)

1. Kitajima H, Sumida Y, Tanaka R, et al. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997;76:F101-7.
2. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014:CD005496.
3. Rao SC, Athalye-Jape GK, Deshpande GC, et al. Probiotic supplementation and late-onset sepsis in preterm infants: a meta-analysis. Pediatrics 2016;137:e20153684-16.
4. Costeloe K, Hardy P, Juszczak E, et al. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016;387:649-60.
5. Yamasaki C, Totsu S, Uchiyama A, et al. Effect of Bifidobacterium administration on very-low-birthweight infants. Pediatr Int 2012;54:651-6.
6. Totsu S, Yamasaki C, Terahara M, et al. Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial. Pediatr Int 2014;56:714-9.
7. Ishii N, Kono Y, Yonemoto N, et al. Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics 2013;132:62-71.
8. Kono Y, Yonemoto N, Kusuda S, et al. Developmental assessment of VLBW infants at 18 months of age: a comparison study between KSPD and Bayley III. Brain Dev 2016;38:377-85.
9. Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-23.
10. Cormack BE, Bloomfield FH, Dezoete A, et al. Does more protein in the first week of life change outcomes for very low birthweight babies? J Paediatr Child Health 2011;47:898-903.
11. Fitzhardinge PM, Steven EM. The small-for-date infant. II. Neurological and intellectual sequelae. Pediatrics 1972;50:50-7.
12. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ 1998;317:1481-7.
13. Pärtty A, Kalliomäki M, Wacklin P, et al. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res 2015;77:823-8.
14. Finegold SM, Downes J, Summanen PH. Microbiology of regressive autism. Anaerobe 2012;18:260-2.
15. Wang L, Christophersen CT, Sorich MJ, et al. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol 2011;77:6718-21.
16. Adams JB, Johansen LJ, Powell LD, et al. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol 2011;11:22.
17. Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013;155:1451-63.
18. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004;558:263-75.
19. Keunen K, van Elburg RM, van Bel F, et al. Impact of nutrition on brain development and its neuroprotective implications following preterm birth. Pediatr Res 2015;77:148-55.